SynthesisTargeted oncology2026
Adjuvant Systemic Therapies After Nephrectomy for Renal Cell Carcinoma: A Bayesian Network Meta-Analysis and Multi-Criteria Benefit-Risk Assessment.
Shugo Yajima et al.PubMed ↗Publisher ↗
No numbers read from the abstract.